The FDA’s expert panel on vaccines met last week (Thursday, January 26, 2023) to discuss the future use of the bivalent COVID shot, signaling the start of the FDA’s pivot to a longer-term immunization strategy. This is an important first step in a process that could result in millions of Americans receiving an annual Covid booster, similar to the flu vaccine. Any such changes will require more discussion and decisions, but the FDA appears to be shifting from responding to the pandemic’s acute phase to a longer-term norm. Dr. Suzanne Judd, Director of the Lister Hill Center for Health Policy and a Professor in the School of Public Health at the University of Alabama at Birmingham, joined the podcast to discuss these topics and the future of COVID-19 vaccinations.
This webinar is presented by the Alabama Regional Center for Infection Prevention and Control Training and Technical Assistance. In this webinar, Dr. Alistair Thorpe will discuss health communication efforts to reduce antibiotic overuse and scope for improving their impact through research on public perceptions and preferences about antibiotics. This webinar is co-sponsored by the Alabama Regional Center for Infection Prevention and Control and the Region IV Public Health Training Center.
The Alabama Regional Center for Infection Prevention and Control Training and Technical Assistance presents “Responding to the 2022 Monkeypox Outbreak.” In this webinar, Dr. Nicolas Van Wagoner, associate professor of Medicine in the Division of Infectious Diseases at the University of Alabama at Birmingham Heersink School of Medicine, will provide a historical overview of monkeypox before 2022 and how the outbreak has reemerged globally, as well as in the United States. This webinar will outline the current state of monkeypox, and the public health response including testing, prevention, and vaccination, as well as provide guidance on communications to prevent misinformation and stigma.
This webinar is co-sponsored by Alabama Regional Center for Infection Prevention and Control Training and Technical Assistance, Region IV Public Health Training Center, and Deep South Center for OH&S .
The Deep South Center for OH&S is an approved provider of continuing education units for nurses by the AL Board of Nursing (Provider ABNP0420 Expiration Date 12/22/2025) and has awarded this program 1.0 contact hours.
The State of Alabama has had a lot of firsts; the first open-heart surgery in the Western Hemisphere was performed in Montgomery in 1902, in 1968 the first 911 call was placed from Haleyville, AL, and unfortunately in 2021 amid the ongoing COVID-19 pandemic Alabama identified their first case of a new Hepatitis outbreak among children under the age of 10. Children in Alabama began to fall ill with symptoms of Hepatitis, an inflammation of the liver that can cause jaundice, fever, fatigue, nausea, vomiting, joint pain, and more symptoms. Despite the mysterious onset and widespread unconnected cases under investigation doctors and other researchers are still trying to pin down the direct cause. The onset of symptoms has not been shown to be related to COVID-19 or its vaccinations, as once thought could be the case. Now, research points to the outbreak possibly being related to a new adenovirus strain. As of June 1, 2022, the outbreak and cause are still under investigation, with 246 cases under investigation of children under the age of ten showing symptoms of hepatitis with an unknown cause across 38 different states with 6 deaths since October 2021. Unfortunately, as is frequently the case with outbreaks, cases have been seen beyond the borders of Alabama or the United States where it started, with cases of hepatitis with an unknown cause among children being reported across the globe with roughly 650 cases spread across 33 different countries. Doctors and researchers are working to determine the cause of the outbreak in order to curb the case count, but until then check out our podcast and the resources below to help you stay informed on the latest happenings in Infection Prevention and Control.
Listen to a podcast from Dr. Wes Stubblefield, District Medical Officer for the Northern and Northeastern Public Health Districts at the Alabama Department of Public Health on this recent outbreak of pediatric hepatitis.
The American Academy of Pediatrics recommends COVID-19 vaccination for most children and adolescents 5 years of age and older. However, as of April 13, 2022 only 28% of children 5-11 years old and 58% of adolescents ages 12-17 have received the 2-dose vaccination series. However, throughout the pandemic, having conversations around COVID-19 and the vaccine has been challenging, especially when it comes to our children. To share her thoughts on the COVID-19 vaccine and children and how to have conversations around the vaccine, we have invited Dr. Candice Dye, an Associate Professor at the University of Alabama at Birmingham and Academic General Pediatrician at Children’s of Alabama, to join us to share her thoughts on this important topic.
This past week the U.S. reported a record single-day number of daily Covid cases, with more than 1 million new infections, according to data compiled by Johns Hopkins University, as the highly infectious omicron variant continues to spread throughout the country and beyond. The The Omicron variant continues to shatter records in the U.S. We’re learning more about the new variant, and, so far, it seems to spread faster but cause less severe illness than previous variants. There is a lot of speculation about the Omicron surge and its aftermath. To help us answer these questions, and for a look at how 2022 might unfold, we invited Dr. Suzanne Judd to join us for this podcast. Dr. Judd is the Director of the Lister Hill Center for Health Policy and a Professor in the School of Public Health at UAB.
This past week the U.S. reported a record single-day number of daily Covid cases, with more than 1 million new infections, according to data compiled by Johns Hopkins University, as the highly infectious omicron variant continues to spread throughout the country and beyond. The U.S. also has the highest seven-day average of daily new cases in any country tracked by Johns Hopkins. Even though Omicron has only been around a short period time, it has quickly made its mark. We have invited Dr. Rachael Lee, Associate Professor in the UAB Division of Infectious Diseases and UAB Health Epidemiologist, to talk about all things related to the Omicron variant.
In this podcast Dr. Ziad Kazzi of Emory University introduces listeners to the basics of cleaning including disinfection and sterilization as well as the proper and safe use of disinfectants to prevent infectious disease transmission.
There are many components of an effective infection prevention and control program. The IPC risk assessment is the starting point for creating an IPC program. A risk assessment is used to identify important infection control issues in your organization and determine goals to include in your infection prevention and control plan. Per The Joint Commission, an annual infection prevention and control (IPC) risk assessment is required to define programmatic goals and objectives and to provide a framework for identifying gaps in services, safety or data as well as tracking progress in meeting specific goals. Today, we are joined by Janet Chance, Director of Infection Prevention, Accreditation, Quality at Cullman Regional Medical Center, and Meredith Lutz, Chief Quality Officer, Medical West Hospital Authority, to discuss risk assessment and planning for infection prevention and control specialists.
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.